Molecular Imaging Market Future Business Opportunities 2021-2028 | Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG

Advances in genomics and the ability to define disease processes based on molecular and cellular alterations hold hope for early illness identification and molecular prevention in some situations. These advancements are being adopted by the area of molecular imaging, which use a variety of technologies to investigate disease states and biology. Molecular labels can be used to analyze tissue microstructures or target individual cells utilizing optical techniques such as variants of fluorescence imaging. Mass spectrometry provides precise information on the chemical composition of operative tissue without the need for molecular probes, making it a novel method for molecular imaging in image-guided surgery.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2191

Molecular imaging is commonly utilized to enhance lung cancer detection and therapy. Molecular imaging is used to reduce the removal of axillary lymph nodes in breast cancer patients by identifying which nodes are more likely to contain cancer cells. PET-CT, a molecular imaging technique, may detect cancer invasion in the body and monitor patient response in severe digestive malignancies. It also aids in the detection and treatment of colorectal cancer by giving information that has a direct impact on treatment alternatives.

Browse 27 Market Data Tables and 31 Figures spread through 180 Pages and in-depth TOC on "Global Molecular Imaging Market, by Technology (Molecular Ultrasound Imaging, Gamma Camera, Optical Imaging, SPECT, Magnetic Resonance Spectroscopy, and PET), by Application (Bone Disorder, Cancer, Brain Disorder, Lung Disorder, Gastrointestinal Disorder, and Heart Disease), by End User (Diagnostic Imaging Centers and Hospital), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa) - Global Forecast to 2026"

Companies are concentrating their efforts on research and development in order to include sophisticated medical technology for in vitro diagnostics. Philips Healthcare got FDA clearance for a spectrum imaging system in 2014. (IQon Spectral CT). The IQon Spectral CT is a cutting-edge, high-performance medical imaging system. According to a research published in 2013 by the Radiological Society of North America, the Philips IQon Spectral CT system improved diagnosis in up to 70 percent of instances when compared to traditional imaging modalities. Targeted therapy, pre-symptomatic identification, and customized medicine will be feasible in the future thanks to rapid technical developments and the use of multimodal molecular imaging. Furthermore, molecular imaging is being used by researchers to explore techniques for creating novel medicines and to plan clinical trials to assess their efficacy. The information given by molecular imaging technologies has the potential to reduce the cost and improve the efficiency of medication development and approval.

Key Takeaways

Due to increased demand for early illness diagnosis and the rising incidence of cancer and other chronic diseases, the global molecular imaging market is anticipated to grow at a CAGR of 8.1 percent over the forecast period (2018–2026).

Due to improved radioactive molecular imaging techniques that can analyze biological reactions and concentrations of molecular targets within a living person, the SPECT market is projected to produce considerable revenue in 2018.

Key companies contributing in the global molecular imaging market are Hologic, Inc., Hitachi Ltd, GE Healthcare, Fujifilm Holdings Corporation, Carestream Health, Toshiba Medical Systems Corporation, Shimadzu Corporation, Samsung Madison, Philips Healthcare, and Siemens AG.

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2191

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.